GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (AMEX:CCEL) » Definitions » Shiller PE Ratio
中文

Cryo-Cell International (Cryo-Cell International) Shiller PE Ratio : 52.47 (As of Apr. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Cryo-Cell International Shiller PE Ratio?

As of today (2024-04-25), Cryo-Cell International's current share price is $7.87. Cryo-Cell International's E10 for the quarter that ended in Feb. 2024 was $0.15. Cryo-Cell International's Shiller PE Ratio for today is 52.47.

The historical rank and industry rank for Cryo-Cell International's Shiller PE Ratio or its related term are showing as below:

CCEL' s Shiller PE Ratio Range Over the Past 10 Years
Min: 11.62   Med: 100   Max: 350
Current: 52.47

During the past years, Cryo-Cell International's highest Shiller PE Ratio was 350.00. The lowest was 11.62. And the median was 100.00.

CCEL's Shiller PE Ratio is ranked worse than
78.38% of 222 companies
in the Healthcare Providers & Services industry
Industry Median: 25.08 vs CCEL: 52.47

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cryo-Cell International's adjusted earnings per share data for the three months ended in Feb. 2024 was $0.067. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.15 for the trailing ten years ended in Feb. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cryo-Cell International Shiller PE Ratio Historical Data

The historical data trend for Cryo-Cell International's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryo-Cell International Shiller PE Ratio Chart

Cryo-Cell International Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 108.37 91.10 91.69 17.41 36.92

Cryo-Cell International Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.69 18.06 21.68 36.92 35.56

Competitive Comparison of Cryo-Cell International's Shiller PE Ratio

For the Medical Care Facilities subindustry, Cryo-Cell International's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International's Shiller PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Shiller PE Ratio falls into.



Cryo-Cell International Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cryo-Cell International's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=7.87/0.15
=52.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International's E10 for the quarter that ended in Feb. 2024 is calculated as:

For example, Cryo-Cell International's adjusted earnings per share data for the three months ended in Feb. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=0.067/129.4194*129.4194
=0.067

Current CPI (Feb. 2024) = 129.4194.

Cryo-Cell International Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201405 0.020 100.373 0.026
201408 0.020 100.352 0.026
201411 -0.030 99.635 -0.039
201502 0.030 99.032 0.039
201505 0.020 100.333 0.026
201508 0.800 100.548 1.030
201511 -0.010 100.135 -0.013
201602 -0.010 100.040 -0.013
201605 0.070 101.355 0.089
201608 -0.350 101.617 -0.446
201611 0.090 101.829 0.114
201702 0.070 102.779 0.088
201705 0.060 103.256 0.075
201708 0.080 103.587 0.100
201711 0.090 104.072 0.112
201802 -0.360 105.052 -0.444
201805 0.070 106.148 0.085
201808 0.030 106.383 0.036
201811 0.130 106.338 0.158
201902 0.030 106.649 0.036
201905 0.010 108.048 0.012
201908 0.130 108.245 0.155
201911 0.100 108.519 0.119
202002 0.080 109.139 0.095
202005 0.120 108.175 0.144
202008 0.100 109.662 0.118
202011 0.150 109.793 0.177
202102 0.080 110.968 0.093
202105 0.140 113.576 0.160
202108 0.100 115.421 0.112
202111 -0.080 117.269 -0.088
202202 0.100 119.703 0.108
202205 0.070 123.323 0.073
202208 0.060 124.958 0.062
202211 0.100 125.607 0.103
202302 0.091 126.928 0.093
202305 0.030 128.314 0.030
202308 0.080 129.538 0.080
202311 -1.340 129.548 -1.339
202402 0.067 129.419 0.067

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cryo-Cell International  (AMEX:CCEL) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cryo-Cell International Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryo-Cell International (Cryo-Cell International) Business Description

Traded in Other Exchanges
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Executives
David Portnoy director, officer: Co-Chief Executive Officer C/O FOCUS FINANCIAL GROUP, 61 HARBOUR WAY, BAL HARBOUR FL 33154
George Gaines director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Jonathan H. Wheeler director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Brian L. Sheehy director 415 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10017
Mark L. Portnoy director, officer: Co-Chief Executive Officer 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Harold D. Berger director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Arthur Ellis director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Mary J Nyberg 10 percent owner 455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050
Cdmj Nyberg Family Trust 10 percent owner 455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050
Jill M Taymans officer: VP, Finance, CFO
Oleg Mikulinsky officer: Chief Information Officer 700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677
Anthony Atala director 700 BROOKER CREEK BOULEVARD, OLDSMAR FL 34677
Scott G Christian director
Sung Won Sohn director 700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677
Michael W. Cho director C/O IOWA STATE UNIVERSITY, 1600 S. 16TH STREET, AMES IA 50011-1250